Results: There were 33 997 patients with a record of death in the ONS data; 33 389 (98.2%) of these were also identified in CPRD. Exact agreement on the death date between CPRD and the ONS was 69.7% across the whole study period, increasing from 53.4% in 1998 to 78.0% in 2013. By 2013, 98.8% of deaths were in agreement within ±30 days.
gold standard. 17 The national HES data contain details of all admissions to National Health Service (NHS) hospitals in England from April 1997, including information on deaths in hospital. 18 Linkage between CPRD GOLD data and the ONS and HES data sources is available at an individual level for those patients registered at practices in England that have consented to data linkage. Linkage between data sets is undertaken using a deterministic linkage algorithm, based on a patient's exact NHS identification number, sex, date of birth, and residential postcode.
A sample of one million patients from CPRD GOLD was identified in January 2014 for a previous publication, based on those who had been registered at a contributing practice for at least 1 day before this date. 14 We used the same sample, restricting it further to those alive when linked ONS death registration data became available (1998; 85.7%) and to those in England (81.5%) who were eligible for linkage with both the ONS data and the HES data (76.8%) to create our study cohort (see Figure SA) . Follow-up time was assessed based on the time since registering at the GP practice until the patient was deducted from the record (transferred out of the practice for any reason). Analyses were restricted to the overlapping coverage period of active follow-up in all three data sources since the influence of the denominator definition is important in studies of linked data. 19 In order to compare the overall mortality rate in CPRD GOLD with the ONS data, we calculated age-standardised mortality rates (ASMRs) standardised to the European Standard Population (ESP) 2013 and compared this with figures published by the ONS using the same methodology. Data from the ONS were available from 2001 onwards. The ESP is an artificial population structure that is used in the weighting of mortality data to produce comparable ASMRs. 20 The population with individual linkage between all three data sources was used to calculate crude mortality rates in each data source and compare them.
Poisson regression was used to calculate rates per 1000 person-years overall and by calendar year from 1998 onwards. We assessed agreement on the fact of death between the CPRD GOLD and the ONS and compared the difference in dates between the two over time.
3 | RESULTS Table 1 describes the random sample of patients with data from 1998 to 2014 (n = 857 047) and the study cohort of 536 341 in England who
KEY POINTS
• The majority of deaths are recorded in UK primary care data.
• The mortality rate calculated for CPRD is comparable with the ONS.
• Where the exact date of death or the cause is important in a CPRD study, it may be advisable to include the individually linked national ONS death registration data.
• Researchers should take into consideration the impact on sample size and power of a study when deciding whether to use the linked data as this can restrict the cohort size substantially.
were eligible for linkage with both the ONS death registration data and the HES data; there were no major differences between the two. In the study cohort, the average follow-up time since registration at the GP 25.4% were non-smokers, 29.6% ex-smokers, and 30.2% smokers.
Smoking information was missing for 86.4% of children, and 11.0%
were recorded as non-smokers. All patients in the subcohort available for linkage were in England, spread across all regions.
ASMRs per 100 000 population, standardised to the ESP 2013, are presented separately for males and females in CPRD GOLD alongside the published national rates from the ONS, which were available from 2001 onwards ( Figure 1 ). In both data sources, the mortality rate was higher for males than females. The mortality rate published by the ONS was higher than calculated for CPRD GOLD for both males and females.
For our study cohort, the crude mortality rate for 1998 to 2013 using the ONS data was 9. There were 33 997 patients with a record of death in the ONS data; 33 389 (98.2%) of these were also in CPRD GOLD ( Figure 3 ).
There were 608 patients with a death recorded in the ONS but not in CPRD GOLD; 498 (82%) had been transferred out of the practice for a reason other than due to death. There were 834 additional patients for whom the algorithm used by CPRD identified a date of death; however, there was no record in the ONS; 802 (96.2%) had been transferred out due to death. There were 17 deaths documented in the HES that
were not recorded in either the ONS or CPRD GOLD data.
Exact agreement between the death date estimated by the CPRD GOLD algorithm and the date from the ONS was 69.7% across the whole study period, increasing from 53.4% in 1998 to 78.0% in 2013
( Figure 4 ). An earlier death date was identified in CPRD GOLD for less than 3%, and this did not change over time. The objective of this study was to compare death date information based on the CPRD GOLD algorithm with national information from the ONS and hospital records, since GPs may not routinely receive information about their deceased patients and there is more than one way to record a death using the primary care software system. We were able to compare the information at the GP practice with the death certificate data by comparing individual records in both data sources.
The CPRD GOLD algorithm has not been externally validated, and This study found that even in recent years, one-fifth of patients have a date of death recorded at the GP practice that is later than the date recorded in the ONS, which is based on the official death certificate. There are several reasons why there may be delayed recording of death information at the GP practice. Firstly, the practice may not be informed within a reasonable time frame. For expected deaths, the registered GP is likely to be informed as soon as it is practicable; however, it is not essential for them to attend to verify a death 23 and the procedure for ensuring the registered GP is notified is not clear. death, which we did not assess in this study. For some conditions, patients are highly likely to be in hospital at the time of death, as was found for heart failure, 26 and certain types of death, such as suicide, may be recorded differently. 27 Further studies could investigate the differences in lag time by cause of death. Delayed recording at the GP practice may contribute to an immeasurable time bias where CPRD GOLD is used for a study without linking to the ONS death registration data. 28 This type of bias is likely to have more impact on case-control study designs that use mortality as an outcome. In this study, we found the median delay to be 16 days. For studies where it is important to be exact on the date of death, it may be advisable to use the linked ONS data in order to minimise including immeasurable person time; however, the impact is likely to be less in more recent years as both the proportion of patients and the median delay have reduced over time. This is in line with the improvement in the completeness of recording of many types of record at the GP practice in recent years.
14 This study used the same random sample of patients from a previous publication, which provided a detailed overview of the data available in CPRD GOLD. 14 The sample was limited to patients eligible for linkage with other data sources and to those with follow-up since 1998. This immediately reduced the original sample of one million patients to 53% in a similar way to previously published studies. 29 Researchers need to balance in the loss in patient numbers alongside the gain in information from the linked data. Several CPRD GOLD studies have used the linked ONS data in order to provide additional information on the cause of death, which would otherwise be less complete in primary care. [30] [31] [32] However, some studies have specifically chosen not to include linked ONS data even when death was an important study outcome, in order to maximise patient numbers and increase external validity by including all four countries of the United Kingdom. 7 In this study, no major differences were found between the original random sample of patients and the subcohort eligible for linkage with both the ONS and the HES data, who were based in England only. In addition, previous studies have shown no difference between mortality rates in a broad CPRD GOLD cohort compared with a subset eligible for linkage. 
